Your browser doesn't support javascript.
loading
Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments.
Hu, Boyu; Patel, Keyur P; Chen, Hsiang-Chun; Wang, Xuemei; Wang, Feng; Luthra, Rajyalakshmi; Routbort, Mark J; Kanagal-Shamanna, Rashmi; Medeiros, Leonard J; Yin, Cheng C; Zuo, Zhuang; Ok, Chi Y; Loghavi, Sanam; Tang, Guilin; Tambaro, Francesco P; Thompson, Philip; Burger, Jan; Jain, Nitin; Ferrajoli, Alessandra; Bose, Prithviraj; Estrov, Zeev; Keating, Michael J; Wierda, William G.
Afiliación
  • Hu B; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute/University of Utah, Salt Lake City, UT, USA.
  • Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chen HC; Department of Biostatistics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang X; Department of Biostatistics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang F; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Luthra R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Routbort MJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yin CC; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zuo Z; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ok CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tambaro FP; S.S.D. TMO - AORN Santobono-Pausilipon, Napoli, Italy.
  • Thompson P; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Burger J; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jain N; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ferrajoli A; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bose P; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Estrov Z; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Keating MJ; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wierda WG; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Br J Haematol ; 185(5): 852-864, 2019 06.
Article en En | MEDLINE | ID: mdl-30924136

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Secuenciación de Nucleótidos de Alto Rendimiento Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Secuenciación de Nucleótidos de Alto Rendimiento Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos